Navigation Links
Insmed to Present at Upcoming Healthcare Conferences
Date:11/5/2008

RICHMOND, Va., Nov. 5 /PRNewswire-FirstCall/ -- Insmed Inc. (Nasdaq: INSM), a developer of follow-on biologics and biopharmaceuticals, announced today that Dr. Geoffrey Allan, President and CEO of Insmed, and Steve Glover, President of Insmed Therapeutic Proteins, will be presenting at the 17th Annual Credit Suisse Healthcare Conference and Rodman & Renshaw 10th Annual Healthcare Conference, respectively.

Dr. Allan will participate on a follow-on biologics-focused panel at the 17th Annual Credit Suisse Healthcare Conference on Wednesday, November 12, 2008 at 3:00 PM MT. The conference will take place in Phoenix, Arizona, from Tuesday, November 11, through Friday, November 14, 2008.

Mr. Glover will be presenting Insmed's corporate presentation on Wednesday, November 12, 2008 at 11:35 AM ET at Rodman & Renshaw's 10th Annual Healthcare Conference in New York City. The conference will take place from Monday, November 10, through Wednesday, November 12, 2008. Insmed's presentation will be webcast live over the Internet and can be accessed directly on http://www.wsw.com/webcast/rrshq14/insm. The webcast will be archived for a period of 90 days.

About Insmed

Insmed Inc. is a biopharmaceutical company with unique protein process development and manufacturing experience and a proprietary protein platform aimed at niche markets with unmet medical needs. For more information, please visit http://www.insmed.com.

Forward-Looking Statements

This release contains forward-looking statements which are made pursuant to provisions of Section 21E of the Securities Exchange Act of 1934. Investors are cautioned that such statements in this release, including statements relating to planned clinical study design, regulatory and business strategies, plans and objectives of management and growth opportunities for existing or proposed products, constitute forward-looking statements which involve risks and uncertainties that could cause actual results to differ materially from those anticipated by the forward-looking statements. The risks and uncertainties include, without limitation, risks that product candidates may fail in the clinic or may not be successfully marketed or manufactured, we may lack financial resources to complete development of product candidates, the FDA may interpret the results of studies differently than us, competing products may be more successful, demand for new pharmaceutical products may decrease, the biopharmaceutical industry may experience negative market trends, our entrance into the follow on biologics market may be unsuccessful, our common stock could be delisted from the Nasdaq Capital Market and other risks and challenges detailed in our filings with the U.S. Securities and Exchange Commission, including our Annual Report on Form 10-K for the year ended December 31, 2007. Readers are cautioned not to place undue reliance on any forward-looking statements which speak only as of the date of this release. We undertake no obligation to publicly release the results of any revisions to these forward-looking statements that may be made to reflect events or circumstances that occur after the date of this release or to reflect the occurrence of unanticipated events.

Investor Relations Contact:

Brian Ritchie - FD

212-850-5683

brian.ritchie@fd.com

Corporate Communications Contact:

John Procter - Gibraltar Associates

202-879-5808

jprocter@gibraltar-llc.com


'/>"/>
SOURCE Insmed Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Insmed to Present at the IBC 5th Annual Global Follow-On Biologics Conference
2. CuraGen to Present at the Rodman & Renshaw Annual Global Investment Conference
3. Lotus Pharmaceuticals to Present at Rodman & Renshaw Conference
4. InVitria to Present at WilBio's International Cell Engineering Meeting
5. Jennerex To Present at Rodman & Renshaw 10th Annual Healthcare Conference
6. Hospira to Present at the 2008 Annual Credit Suisse Health Care Conference on November 12
7. Alexion to Present at Investor Conferences
8. IPC The Hospitalist Company, Inc. to Present at the 2008 Annual Credit Suisse Health Care Conference
9. Jazz Pharmaceuticals to Present at Investor Conferences
10. Senesco Technologies to Present at 10th Annual Rodman & Renshaw Healthcare Conference
11. XOMA to Present at the Rodman and Renshaw Annual Global Investment Conference on November 11
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2017)... ... 23, 2017 , ... Drs. Allen Huang and Jeffrey Wang, ... Las Vegas, NV, and the importance of treating it immediately. They are now ... for peri-implantitis, with or without a referral. As experienced periodontists and implant specialists, ...
(Date:5/23/2017)... ... May 23, 2017 , ... Diagnotes, an Indianapolis-based digital ... feature on its secure clinical communication platform. The platform allows clinicians to easily ... the type and urgency of a situation. , “We know from our ...
(Date:5/23/2017)... ... May 23, 2017 , ... Orbita’s Nathan Treloar will discuss the role of ... Francisco. Titled Connected Health and IoT: Technology Innovators and Disruption , the workshop ... Associates, a market research and consulting firm specializing in emerging consumer technology products and ...
(Date:5/23/2017)... ... 23, 2017 , ... New patients looking for an alternative ... or without a referral, from the multi-specialty Dr. Smile practice. Dr. Esther Feldman ... in providing patients with the custom, convenient and long-lasting orthodontic treatment that helps ...
(Date:5/23/2017)... Mt. Horeb, WI (PRWEB) , ... May 23, 2017 , ... ... now invited to call Dr. Angela Cotey’s practice to schedule an appointment, with or ... dentistry services, and frequently offers pulpotomy treatments to pediatric patients as a healthy alternative ...
Breaking Medicine News(10 mins):
(Date:5/4/2017)... Fix Inc. (" Fortuna "), a private, clinical-stage biotech ... need for embryonic and fetal stem cells by using direct ... Fortuna announced today the launch of its Scientific ... PhD; Father Kevin FitzGerald , S.J., PhD; Col. (R) ... Giordano , PhD. "We are excited and honored ...
(Date:5/4/2017)... , May 4, 2017  DarioHealth Corp. (NASDAQ: ... health and big data solutions, today announced that it ... Company, and STI Technologies Limited to lower diabetes healthcare ... Through STI,s innoviCares card, which is available throughout all ... DarioHealth customers will be eligible for additional savings when ...
(Date:5/3/2017)... ROCKVILLE, Md. , May 3, 2017 /PRNewswire/ ... revenue growth of nine percent next year and ... solid organ and hematopoietic stem cell (HSCT) or ... and donor. Molecular testing technologies are well-suited for this ... healthcare-only market research publisher Kalorama Information. The various ...
Breaking Medicine Technology: